Evidence map›Paper›PMID 42072415›Full record

ArticleBiomedicines2026

Prophylactic Nebulized hUC-MSC-EVs Attenuate Hypobaric Hypoxia-Induced Lung Injury via Alveolar-Capillary Barrier Stabilization and TEK/Tie2 Preservation.

Peixin Wu, Yue Yin, Jinxia Liu, Zhenfei Mo, Jiabo Ren, Xiuqing Ma, Zhixin Liang, Miaoyu Wang, Chunsun Li, Liangan Chen

Abstract read
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Peixin WuSchool of Medicine, Nankai University, Tianjin 300071, China.
Yue YinDepartment of Pulmonary and Critical Care Medicine, Eighth Medical Center, Chinese PLA General Hospital, Beijing 100091, China.
Jinxia LiuDepartment of Pulmonary and Critical Care Medicine, Eighth Medical Center, Chinese PLA General Hospital, Beijing 100091, China.ORCID 0009-0003-7025-8584
Zhenfei MoDepartment of Pulmonary and Critical Care Medicine, Eighth Medical Center, Chinese PLA General Hospital, Beijing 100091, China.
Jiabo RenDepartment of Pulmonary and Critical Care Medicine, Eighth Medical Center, Chinese PLA General Hospital, Beijing 100091, China.
Xiuqing MaDepartment of Pulmonary and Critical Care Medicine, Eighth Medical Center, Chinese PLA General Hospital, Beijing 100091, China.
Zhixin LiangDepartment of Pulmonary and Critical Care Medicine, Eighth Medical Center, Chinese PLA General Hospital, Beijing 100091, China.
Miaoyu WangDepartment of Respiratory and Critical Care Medicine, Second Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
Chunsun LiDepartment of Pulmonary and Critical Care Medicine, Eighth Medical Center, Chinese PLA General Hospital, Beijing 100091, China.ORCID 0009-0004-6731-2145
Liangan ChenSchool of Medicine, Nankai University, Tianjin 300071, China.

Funding

the National Key Research and Development Program of China grant number 2022YFA1104704
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alveolar–capillary barrierhigh-altitude pulmonary edemahypobaric hypoxialung-targeted deliveryoxidative stressprophylactic nebulized hUC-MSC-EVsTEKTie2

Identifiers

PMID42072415
PMCPMC13113225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.